A machine learning approach to identify predictive molecular markers for cisplatin chemosensitivity following surgical resection in ovarian cancer | Scientific Reports
Frontiers | Pre-diagnosis Cruciferous Vegetables and Isothiocyanates Intake and Ovarian Cancer Survival: A Prospective Cohort Study
Ovarian Cancer Immunotherapy en Route: IL9 Inhibits Growth of Ovarian Cancer and Upregulates its Expression of Ox40L and 4-1BBL
Cancers | Free Full-Text | An Overview of Candidate Therapeutic Target Genes in Ovarian Cancer
Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium | British Journal of Cancer
Cancers | Free Full-Text | Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study
IJMS | Free Full-Text | Strategy for Pre-Clinical Development of Active Targeting MicroRNA Oligonucleotide Therapeutics for Unmet Medical Needs
CIMB | Free Full-Text | Immunotherapeutic Approaches in Ovarian Cancer
The epigenetic correlation among ovarian cancer, endometriosis and PCOS: A review - ScienceDirect
An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study | British Journal of Cancer
Biomedicines | Free Full-Text | The Role of the Adipokine Resistin in the Pathogenesis and Progression of Epithelial Ovarian Cancer
Pharmaceutics | Free Full-Text | Potential Role of Vaginal Microbiota in Ovarian Cancer Carcinogenesis, Progression and Treatment
Frontiers | Disease Burden and Attributable Risk Factors of Ovarian Cancer From 1990 to 2017: Findings From the Global Burden of Disease Study 2017
METTL3 promotes the initiation and metastasis of ovarian cancer by inhibiting CCNG2 expression via promoting the maturation of pri-microRNA-1246 | Cell Death Discovery
RNA epigenetic modifications in ovarian cancer: The changes, chances, and challenges - Ye - WIREs RNA - Wiley Online Library
Statin use and survival among women with ovarian cancer: an Australian national data-linkage study | British Journal of Cancer
Blood bioactive sphingolipids in patients with advanced serous epithelial ovarian cancer – mass spectrometry analysis
PDF) The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer
Epidemiology of epithelial ovarian cancer - ScienceDirect
Bibliometric analysis of hotspots and frontiers in cancer-related fatigue among ovarian cancer survivors | PLOS ONE
Frontiers | Association Between Benign Ovarian Tumors and Ovarian Cancer Risk: A Meta-Analysis of Ten Epidemiological Studies
Frontiers | Identification of NAD+ Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy
Exploiting epigenetic dependencies in ovarian cancer therapy - Coughlan - 2021 - International Journal of Cancer - Wiley Online Library
Targeted Detection of Cyclooxygenase-1 in Ovarian Cancer | ACS Medicinal Chemistry Letters
